Motavizumab

Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research.
Read more
€0.00 (tax incl.)
Reference:
HY-P99209
Product Details
HY-P99209

Data sheet

Size
Multiple sizes
Reactivity
RSV
Application
COVID-19-anti-virus
CAS
677010-34-3

Menu

Settings